top of page

Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study
Bhanpuri, Nasir H.; Hallberg, Sarah J.; Williams, Paul T.; McKenzie, Amy L.; Ballard, Kevin D.; Campbell, Wayne W.; McCarter, James P.; Phinney, Stephen D.; Volek, Jeff S.
Abstract:
BACKGROUND: Cardiovascular disease (CVD) is a leading cause of death among adults with type 2 diabetes mellitus (T2D). We recently reported that glycemic control in patients with T2D can be significantly improved through a continuous care intervention (CCI) including nutritional ketosis. The purpose of this study was to examine CVD risk factors in this cohort. METHODS: We investigated CVD risk factors in patients with T2D who participated in a 1 year open label, non-randomized, controlled study. The CCI group (n = 262) received treatment from a health coach and medical provider. A usual care (UC) group (n = 87) was independently recruited to track customary T2D progression. Circulating biomarkers of cholesterol metabolism and inflammation, blood pressure (BP), carotid intima media thickness (cIMT), multi-factorial risk scores and medication use were examined. A significance level of P < 0.0019 ensured two-tailed significance at the 5% level when Bonferroni adjusted for multiple comparisons. RESULTS: The CCI group consisted of 262 participants (baseline mean (SD): age 54 (8) year, BMI 40.4 (8.8) kg m-2). Intention-to-treat analysis (% change) revealed the following at 1-year: total LDL-particles (LDL-P) (- 4.9%, P = 0.02), small LDL-P (- 20.8%, P = 1.2 × 10-12), LDL-P size (+ 1.1%, P = 6.0 × 10-10), ApoB (- 1.6%, P = 0.37), ApoA1 (+ 9.8%, P < 10-16), ApoB/ApoA1 ratio (- 9.5%, P = 1.9 × 10-7), triglyceride/HDL-C ratio (- 29.1%, P < 10-16), large VLDL-P (- 38.9%, P = 4.2 × 10-15), and LDL-C (+ 9.9%, P = 4.9 × 10-5). Additional effects were reductions in blood pressure, high sensitivity C-reactive protein, and white blood cell count (all P
Automatic Tags
Female; Humans; Male; Adult; Inflammation; Middle Aged; Risk Factors; Nutritional Status; Time Factors; Diet, Carbohydrate-Restricted; Biomarkers; Lipids; Prospective Studies; Ketosis; Treatment Outcome; Diabetes Mellitus, Type 2; Blood Glucose; Combined Modality Therapy; Hypoglycemic Agents; 3-Hydroxybutyric Acid; Diet, Diabetic; Inflammation Mediators; Indiana; Antihypertensive medication; Atherogenic dyslipidemia; Continuous remote care; Delivery of Health Care, Integrated; Risk factor; Type diabetes; Carbohydrate restriction; Diabetic Ketoacidosis
bottom of page

